Diabetic Retinopathy Eye Care: Protecting Your Vision with Diabetes

What Is Diabetic Retinopathy?

Diabetic retinopathy (DR) is the most common microvascular complication of diabetes and the leading cause of preventable blindness in working-age adults in the UK. It affects approximately 1 in 3 people with diabetes to some degree, with around 1,700 people losing their sight to the condition each year.

DR develops when chronically elevated blood glucose damages the small blood vessels (capillaries) that supply the retina — the light-sensitive tissue lining the back of the eye. Over time, these vessels leak, become blocked, or stimulate the growth of fragile new vessels that bleed into the vitreous, threatening vision.

Stages of Diabetic Retinopathy

DR is classified into two broad categories:

• Non-proliferative diabetic retinopathy (NPDR) — the early stage, characterised by microaneurysms (tiny bulges in vessel walls), retinal haemorrhages, and hard exudates (lipid deposits). Vision may be unaffected at this stage, which is why regular screening is critical.
• Proliferative diabetic retinopathy (PDR) — the advanced stage, where new abnormal blood vessels grow across the retina and into the vitreous (neovascularisation). These vessels are fragile and prone to bleeding, causing sudden, severe vision loss.

A related condition, diabetic macular oedema (DMO), can occur at any stage and involves fluid accumulation in the macula, causing blurred central vision. DMO is the most common cause of vision loss in people with diabetes.

Risk Factors and Progression

The duration of diabetes is the single strongest predictor of DR development — after 20 years with diabetes, nearly all people with type 1 and over 60% with type 2 will have some degree of retinopathy. Key modifiable risk factors include:

• Poor glycaemic control — HbA1c above target is the primary driver of retinal damage
• Hypertension — elevated blood pressure accelerates vascular damage in the retina
• Dyslipidaemia — high LDL cholesterol is associated with hard exudate formation and DMO
• Smoking — impairs microvascular circulation and worsens retinal ischaemia
• Nephropathy — kidney disease is strongly correlated with more severe retinopathy
• Pregnancy — can accelerate DR progression in women with pre-existing diabetes

The UK Diabetic Eye Screening Programme

All people with diabetes aged 12 and over in England are invited for annual diabetic eye screening — a digital retinal photograph that can detect early changes before symptoms develop. This programme has been instrumental in reducing blindness from DR, as early-stage disease is largely asymptomatic.

Do not wait for symptoms. By the time vision is affected, significant retinal damage has often already occurred. Attending every annual screening appointment is the single most important action a person with diabetes can take for their eye health.

Medical Treatments for Diabetic Retinopathy

Treatment depends on the stage and severity of DR:

• Anti-VEGF injections (ranibizumab, aflibercept, bevacizumab) — the gold-standard treatment for PDR and DMO. These drugs block vascular endothelial growth factor, the protein that drives abnormal vessel growth and leakage.
• Laser photocoagulation — pan-retinal photocoagulation (PRP) is used in PDR to destroy ischaemic retinal tissue and reduce the stimulus for neovascularisation. Focal/grid laser is used for DMO.
• Intravitreal corticosteroids — dexamethasone implants (Ozurdex) are used for DMO in patients unsuitable for anti-VEGF therapy.
• Vitrectomy — surgical removal of the vitreous is indicated for non-clearing vitreous haemorrhage or tractional retinal detachment in advanced PDR.

The Role of Nutritional Supplementation in Retinal Protection

While medical treatment addresses established disease, nutritional supplementation plays an important complementary role in supporting retinal health and mitigating oxidative and inflammatory damage — key mechanisms in DR pathogenesis.

Antioxidants and Oxidative Stress

Chronic hyperglycaemia generates excessive reactive oxygen species (ROS), overwhelming the retina's natural antioxidant defences. Nutrients with antioxidant activity — including vitamin C, vitamin E, alpha-lipoic acid, and lutein — help neutralise ROS and protect retinal capillary endothelial cells from oxidative damage.

Bilberry Extract

Bilberry (Vaccinium myrtillus) is rich in anthocyanins, which have demonstrated vasoprotective and antioxidant properties in preclinical and clinical studies. Anthocyanins stabilise collagen in capillary walls, improve microcirculation, and reduce vascular permeability — mechanisms directly relevant to DR pathophysiology.

Zinc and Copper

Zinc is a cofactor for superoxide dismutase, a key antioxidant enzyme in the retina. Adequate zinc status supports the retina's intrinsic defence against oxidative stress. Copper is included alongside zinc to prevent zinc-induced copper deficiency.

Omega-3 Fatty Acids

DHA, the predominant omega-3 in the retina, has anti-inflammatory and neuroprotective properties. Emerging evidence suggests omega-3 supplementation may help preserve retinal function in early DR by modulating inflammatory pathways and supporting photoreceptor membrane integrity.

Glycoshield™: Targeted Nutritional Support for Diabetic Retinal Health

Glycoshield™ is Ocular Express's specialist supplement formulated specifically for individuals with diabetes who wish to support their retinal health nutritionally. It combines evidence-informed ingredients — including antioxidants, bilberry extract, and key micronutrients — in therapeutic doses designed to complement, not replace, medical management and screening.

For comprehensive retinal and macular support, the Ultimate Retinal & Macular Health Bundle pairs Glycoshield™ with Macusure™ for a complete nutritional protocol.

Practical Steps to Protect Your Vision with Diabetes

• Attend every annual diabetic eye screening appointment — non-negotiable
• Optimise glycaemic control — work with your diabetes team to achieve and maintain your HbA1c target
• Manage blood pressure — target below 130/80 mmHg in people with diabetes and retinopathy
• Address dyslipidaemia — statin therapy and dietary modification reduce hard exudate risk
• Stop smoking — smoking cessation is one of the most impactful modifiable interventions
• Exercise regularly — improves insulin sensitivity and microvascular health
• Consider targeted nutritional support — as a complement to the above, not a substitute

When to Seek Urgent Eye Care

Contact your GP, optometrist, or eye casualty immediately if you experience:

• Sudden loss of vision in one or both eyes
• A sudden increase in floaters or flashing lights
• A dark curtain or shadow across your vision
• Rapid deterioration in visual acuity

These symptoms may indicate vitreous haemorrhage or retinal detachment — both ophthalmic emergencies requiring urgent assessment.

This article is intended for informational purposes only and does not constitute medical advice. Always consult your diabetes care team and a qualified eye care professional regarding your individual circumstances.